Neuren Pharmaceuticals LimitedASX: NEU

Prader-Willi syndrome IND for NNZ-2591 approved by FDA

Jan 23, 2023 at 3:52 AM UTC · Issued by Neuren Pharmaceuticals Limited

Neuren Pharmaceuticals Ltd has released a press release.

View Attachment